✦ LIBER ✦

The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based study

✍ Scribed by Gandaglia, Giorgio; Sun, Maxine; Popa, Ioana; Schiffmann, Jonas; Abdollah, Firas; Trinh, Quoc-Dien; Saad, Fred; Graefen, Markus; Briganti, Alberto; Montorsi, Francesco; Karakiewicz, Pierre I.

Book ID: 121649856
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 556 KB
Volume: 114
Category: Article
ISSN: 1464-4096
DOI: 10.1111/bju.12732

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meta-analysis of the Impact of Androgen

Meta-analysis of the Impact of Androgen Deprivation Therapy on Cardiovascular Death in Patients with Prostate Cancer

✍ P.L. Nguyen; Y. Je; F.A.B. Schutz; K.E. Hoffman; J.C. Hu; J.A. Beckman; T.K. Cho 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 47 KB

976 Risk of venous thromboembolism among

976 Risk of venous thromboembolism among prostate cancer patients treated with androgen deprivation therapy in Denmark: A population-based cohort study, 1997-2011

✍ Nguyen-Nielsen, M.; Borre, M.; Horváth-Puhó, E.; Ehrenstein, V.; Sørensen, H.T. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 112 KB

The Effects of Long-Term Androgen Depriv

The Effects of Long-Term Androgen Deprivation Therapy on Penile Length in Patients with Prostate Cancer: A Single-Center, Prospective, Open-Label, Observational Study

✍ Kyung Kgi Park; Seung Hwan Lee; Byung Ha Chung 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

980 A randomized phase 2 study evaluatin

980 A randomized phase 2 study evaluating the optimal sequencing of sipuleucel-T and androgen deprivation therapy (ADT) in biochemically-recurrent prostate cancer (BRPC): Immune results with a focus on humoral responses

✍ Antonarakis, E.S.; Kibel, A.S.; Adams, G.W.; Karsh, L.I.; Elfiky, A.; Shore, N.D 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 202 KB

A population-based study evaluating the

A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer

✍ Daniel Y. C. Heng; Kim N Chi; Nevin Murray; Tao Jin; Jorge A Garcia; Ronald M Bu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

## Abstract ## BACKGROUND: Sunitinib has replaced interferon (IFN) as a first‐line standard of care in the treatment of metastatic renal cell carcinoma (RCC). This study aimed to determine overall survival and to confirm effectiveness in a population that includes poor prognosis patients. ## METH

A Population-based Study Evaluating the

A Population-based Study Evaluating the Impact of Sunitinib on Overall Survival in the Treatment of Patients With Metastatic Renal Cell Cancer

✍ Coplen, D.E. 📂 Article 📅 2009 🏛 Elsevier Science ⚖ 50 KB